Effect	effect	O	O
of	of	O	O
increasing	increasing	O	O
intraperitoneal	intraperitoneal	O	O
infusion	infusion	O	O
rates	rates	O	O
on	on	O	O
bupropion	bupropion	S_chemical	O
hydrochloride-induced	hydrochloride-induced	O	O
seizures	seizures	O	S_disease
in	in	O	O
mice	mice	O	O
.	.	O	O

BACKGROUND	background	O	O
:	:	O	O
It	it	O	O
is	is	O	O
not	not	O	O
known	known	O	O
if	if	O	O
there	there	O	O
is	is	O	O
a	a	O	O
relationship	relationship	O	O
between	between	O	O
input	input	O	O
rate	rate	O	O
and	and	O	O
incidence	incidence	O	O
of	of	O	O
bupropion-induced	bupropion-induced	O	O
seizures	seizures	O	S_disease
.	.	O	O

This	this	O	O
is	is	O	O
important	important	O	O
,	,	O	O
since	since	O	O
different	different	O	O
controlled	controlled	O	O
release	release	O	O
formulations	formulations	O	O
of	of	O	O
bupropion	bupropion	S_chemical	O
release	release	O	O
the	the	O	O
active	active	O	O
drug	drug	O	O
at	at	O	O
different	different	O	O
rates	rates	O	O
.	.	O	O

METHODS	methods	O	O
:	:	O	O
We	we	O	O
investigated	investigated	O	O
the	the	O	O
effect	effect	O	O
of	of	O	O
varying	varying	O	O
the	the	O	O
intraperitoneal	intraperitoneal	O	O
infusion	infusion	O	O
rates	rates	O	O
of	of	O	O
bupropion	bupropion	S_chemical	O
HCl	hcl	O	O
120	120	O	O
mg/kg	mg/kg	O	O
,	,	O	O
a	a	O	O
known	known	O	O
convulsive	convulsive	O	S_disease
dose	dose	O	O
50	50	O	O
(	(	O	O
CD50	cd50	O	O
)	)	O	O
,	,	O	O
on	on	O	O
the	the	O	O
incidence	incidence	O	O
and	and	O	O
severity	severity	O	O
of	of	O	O
bupropion-induced	bupropion-induced	O	O
convulsions	convulsions	O	S_disease
in	in	O	O
the	the	O	O
Swiss	swiss	O	O
albino	albino	O	O
mice	mice	O	O
.	.	O	O

A	a	O	O
total	total	O	O
of	of	O	O
69	69	O	O
mice	mice	O	O
,	,	O	O
approximately	approximately	O	O
7	7	O	O
weeks	weeks	O	O
of	of	O	O
age	age	O	O
,	,	O	O
and	and	O	O
weighing	weighing	O	O
21.0	21.0	O	O
to	to	O	O
29.1	29.1	O	O
g	g	O	O
were	were	O	O
randomly	randomly	O	O
assigned	assigned	O	O
to	to	O	O
bupropion	bupropion	S_chemical	O
HCl	hcl	O	O
120	120	O	O
mg/kg	mg/kg	O	O
treatment	treatment	O	O
by	by	O	O
intraperitoneal	intraperitoneal	O	O
(	(	O	O
IP	ip	O	O
)	)	O	O
administration	administration	O	O
in	in	O	O
7	7	O	O
groups	groups	O	O
(	(	O	O
9	9	O	O
to	to	O	O
10	10	O	O
animals	animals	O	O
per	per	O	O
group	group	O	O
)	)	O	O
.	.	O	O

Bupropion	bupropion	S_chemical	O
HCl	hcl	O	O
was	was	O	O
infused	infused	O	O
through	through	O	O
a	a	O	O
surgically	surgically	O	O
implanted	implanted	O	O
IP	ip	O	O
dosing	dosing	O	O
catheter	catheter	O	O
with	with	O	O
infusions	infusions	O	O
in	in	O	O
each	each	O	O
group	group	O	O
of	of	O	O
0	0	O	O
min	min	O	O
,	,	O	O
15	15	O	O
min	min	O	O
,	,	O	O
30	30	O	O
min	min	O	O
,	,	O	O
60	60	O	O
min	min	O	O
,	,	O	O
90	90	O	O
min	min	O	O
,	,	O	O
120	120	O	O
min	min	O	O
,	,	O	O
and	and	O	O
240	240	O	O
min	min	O	O
.	.	O	O

The	the	O	O
number	number	O	O
,	,	O	O
time	time	O	O
of	of	O	O
onset	onset	O	O
,	,	O	O
duration	duration	O	O
and	and	O	O
the	the	O	O
intensity	intensity	O	O
of	of	O	O
the	the	O	O
convulsions	convulsions	O	S_disease
or	or	O	O
absence	absence	O	O
of	of	O	O
convulsions	convulsions	O	S_disease
were	were	O	O
recorded	recorded	O	O
.	.	O	O

RESULTS	results	O	O
:	:	O	O
The	the	O	O
results	results	O	O
showed	showed	O	O
that	that	O	O
IP	ip	O	O
administration	administration	O	O
of	of	O	O
bupropion	bupropion	S_chemical	O
HCl	hcl	O	O
120	120	O	O
mg/kg	mg/kg	O	O
by	by	O	O
bolus	bolus	O	O
injection	injection	O	O
induced	induced	O	O
convulsions	convulsions	O	S_disease
in	in	O	O
6	6	O	O
out	out	O	O
of	of	O	O
10	10	O	O
mice	mice	O	O
(	(	O	O
60	60	O	O
%	%	O	O
of	of	O	O
convulsing	convulsing	O	O
mice	mice	O	O
)	)	O	O
in	in	O	O
group	group	O	O
1	1	O	O
.	.	O	O

Logistic	logistic	O	O
regression	regression	O	O
analysis	analysis	O	O
revealed	revealed	O	O
that	that	O	O
infusion	infusion	O	O
time	time	O	O
was	was	O	O
significant	significant	O	O
(	(	O	O
p	p	O	O
=	=	O	O
0.0004	0.0004	O	O
;	;	O	O
odds	odds	O	O
ratio	ratio	O	O
=	=	O	O
0.974	0.974	O	O
)	)	O	O
and	and	O	O
increasing	increasing	O	O
the	the	O	O
IP	ip	O	O
infusion	infusion	O	O
time	time	O	O
of	of	O	O
bupropion	bupropion	S_chemical	O
HCl	hcl	O	O
120	120	O	O
mg/kg	mg/kg	O	O
was	was	O	O
associated	associated	O	B_disease
with	with	O	I_disease
a	a	O	O
91	91	O	O
%	%	O	O
reduced	reduced	O	O
odds	odds	O	O
of	of	O	O
convulsions	convulsions	O	S_disease
at	at	O	O
infusion	infusion	O	O
times	times	O	O
of	of	O	O
15	15	O	O
to	to	O	O
90	90	O	O
min	min	O	O
compared	compared	O	O
to	to	O	O
bolus	bolus	O	O
injection	injection	O	O
.	.	O	O

Further	further	O	O
increase	increase	O	O
in	in	O	O
infusion	infusion	O	O
time	time	O	O
resulted	resulted	O	O
in	in	O	O
further	further	O	O
reduction	reduction	O	O
in	in	O	O
the	the	O	O
odds	odds	O	O
of	of	O	O
convulsions	convulsions	O	S_disease
to	to	O	O
99.8	99.8	O	O
%	%	O	O
reduction	reduction	O	O
at	at	O	O
240	240	O	O
min	min	O	O
.	.	O	O

CONCLUSION	conclusion	O	O
:	:	O	O
In	in	O	O
conclusion	conclusion	O	O
,	,	O	O
the	the	O	O
demonstration	demonstration	O	O
of	of	O	O
an	an	O	O
inverse	inverse	O	O
relationship	relationship	O	O
between	between	O	O
infusion	infusion	O	O
time	time	O	O
of	of	O	O
a	a	O	O
fixed	fixed	O	O
and	and	O	O
convulsive	convulsive	O	S_disease
dose	dose	O	O
of	of	O	O
bupropion	bupropion	S_chemical	O
and	and	O	O
the	the	O	O
risk	risk	O	O
of	of	O	O
convulsions	convulsions	O	S_disease
in	in	O	O
a	a	O	O
prospective	prospective	O	O
study	study	O	O
is	is	O	O
novel	novel	O	O
.	.	O	O

